Johnson & Johnson MedTech’s INHANCE INTACT™ is an instrumentation system intended for use in subscapularis-sparing total shoulder arthroplasty (TSA) procedure.
It enables replacement of the shoulder joint while keeping the subscapularis muscle intact.
Recommended White Papers
Recommended Buyers Guides
The system obtained 510(k) clearance from the US Food and Drug Administration (FDA) in December 2024 and is available for clinical use in the US.
INHANCE INTACT™ was also featured at the American Shoulder and Elbow Surgeons (ASES) Annual Meeting in October 2025 in San Diego, California.
INHANCE INTACT design and features
The INHANCE INTACT™ instrumentation system includes a stemless implant and is designed to be used along with the INHANCE™ Shoulder System, a set of 43 instruments, and TRUMATCH™ Personalised Solutions to support patient-specific 3D planning, limit bone removal and maintain operative accuracy.
This combination is intended to help achieve reproducible results in different healthcare settings.
It allows surgeons to carry out a range of shoulder replacement procedures with fewer operative steps, a unified construct, and reduced operating time.
The instruments and associated techniques are designed so that TSA can be performed without detaching the subscapularis tendon.
INHANCE Shoulder System details
The INHANCE™ Shoulder System with a humeral stem is designed for use in shoulder joint replacement surgeries, including anatomic total shoulder arthroplasty, reverse TSA, and hemiarthroplasty procedures.
It was created in collaboration with shoulder arthroplasty surgeons to respond to the rising complexity of shoulder replacement procedures by including less invasive options.
The system is intended to limit bone removal, support both early and long-term fixation, and allow flexibility during surgery, while simplifying preparation for a range of surgical approaches.
The system allows surgeons to switch between stemless and stemmed implants during the operation when required.
TRUMATCH Personalised Solutions Shoulder System details
The TRUMATCH™ Personalised Solutions Shoulder System is used by surgeons to review the glenohumeral joint structure in three dimensions and prepare the surgical approach accordingly.
Its role is to guide the placement of glenoid components during anatomic or reverse shoulder arthroplasty, based on anatomical reference points visible on pre-operative CT imaging.
The system is designed to be used along with an ergonomically designed glenoid guide.
It can be used with a range of shoulder systems, including the GLOBAL™ APG+ Shoulder System, the GLOBAL™ STEPTECH® APG Shoulder System, the DELTA XTEND™ Reverse Shoulder System and associated components.
Johnson & Johnson INHANCE INTACT system benefits
Johnson & Johnson MedTech’s INHANCE INTACT™ is an instrumentation system intended for use in subscapularis-sparing total shoulder arthroplasty (TSA) procedure.
It enables replacement of the shoulder joint while keeping the subscapularis muscle intact.
The system obtained 510(k) clearance from the US Food and Drug Administration (FDA) in December 2024 and is available for clinical use in the US.
INHANCE INTACT was also featured at the American Shoulder and Elbow Surgeons (ASES) Annual Meeting in October 2025 in San Diego, California.
INHANCE INTACT design and features
The INHANCE INTACT instrumentation system includes a stemless implant and is designed to be used along with the INHANCE™ Shoulder System, a set of 43 instruments, and TRUMATCH™ Personalised Solutions to support patient-specific 3D planning, limit bone removal and maintain operative accuracy.
This combination is intended to help achieve reproducible results in different healthcare settings.
It allows surgeons to carry out a range of shoulder replacement procedures with fewer operative steps, a unified construct and reduced operating time.
The instruments and associated techniques are designed so that TSA can be performed without detaching the subscapularis tendon.
INHANCE Shoulder System details
The INHANCE Shoulder System with a humeral stem is designed for use in shoulder joint replacement surgeries, including anatomic total shoulder arthroplasty, reverse TSA and hemiarthroplasty procedures.
It was created in collaboration with shoulder arthroplasty surgeons to respond to the rising complexity of shoulder replacement procedures by including less invasive options.
The system is intended to limit bone removal, support both early and long-term fixation, and allow flexibility during surgery, while simplifying preparation for a range of surgical approaches.
The system allows surgeons to switch between stemless and stemmed implants during the operation when required.
TRUMATCH Personalised Solutions Shoulder System details
The TRUMATCH Personalised Solutions Shoulder System is used by surgeons to review the glenohumeral joint structure in three dimensions and prepare the surgical approach accordingly.
Its role is to guide the placement of glenoid components during anatomic or reverse shoulder arthroplasty, based on anatomical reference points visible on pre-operative computed tomography (CT) imaging.
The system is designed to be used along with an ergonomically designed glenoid guide.
It can be used with a range of shoulder systems, including the GLOBAL™ APG+ Shoulder System, the GLOBAL™ STEPTECH® APG Shoulder System, the DELTA XTEND™ Reverse Shoulder System and associated components.
Johnson & Johnson INHANCE INTACT system benefits
In the standard deltopectoral approach for TSA, the subscapularis tendon at the front of the shoulder is usually detached.
This has been associated with post-operative pain, instability and tendon problems, and commonly requires immobilisation of the arm for up to six weeks after surgery.
A subscapularis-sparing, tissue-preserving technique, as used with INHANCE INTACT, offers a different method of gaining access to the joint.
This approach can provide clearer access to the joint compared with the traditional technique and may support earlier progression of rehabilitation.
When the subscapularis tendon is preserved, patients can usually begin moving the shoulder without specific restrictions from the first day after surgery, instead of remaining immobilised for several weeks.
Preservation of this tendon can have clinical, practical and financial implications for patients, surgeons and healthcare facilities.
Earlier functional recovery and shorter hospital stays after shoulder replacement may reduce overall costs and affect patient-reported experience, and this approach may be appropriate for use in ambulatory surgery centres.
Marketing commentary on Johnson & Johnson
Johnson & Johnson is a US-based healthcare company that develops medical products and treatments intended to reduce the need for highly invasive procedures.
The organisation is structured into two main segments: innovative medicine and medtech, which together address a broad range of healthcare needs.
Innovative medicine covers fields such as oncology, immunology, neuroscience and cardiopulmonary conditions.
MedTech concentrates on areas including cardiovascular care, orthopaedics, surgical interventions and vision.